Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Obstetrics and Gynecology Clinics of North America|December 9, 2008
Cervical cancer screening in pregnancyKathleen McIntyre-Seltman, Jamie L LesnockJournal of Graduate Medical Education|October 7, 2011
Residents as role models: the effect of the obstetrics and gynecology clerkship on medical students' career interestJudy C Chang, Michele R Odrobina, Kathleen McIntyre-SeltmanJournal of Women'S Health (2002)|January 22, 2010
The effect of student gender on the obstetrics and gynecology clerkship experienceJudy C Chang, Michele R Odrobina, Kathleen McIntyre-SeltmanCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytologyKathleen McIntyre-Seltman, Philip E Castle, Richard Guido, et al.Gynecologic Oncology|March 19, 2013
Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysisJamie L Lesnock, Coreen Farris, Sushil Beriwal, et al.Journal of Lower Genital Tract Disease|October 20, 2006
Colposcopically obtained images of vulvar, vaginal, and cervical epithelium for assessment of safety of intravaginal agents among normal adolescent females: comparison with in vivo exam and interobserver agreementRichard S Guido, Barb J Cardinal-Busse, Kathleen McIntyre-Seltman, et al.Gynecologic Oncology|June 14, 2011
Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancerJamie L Lesnock, Coreen Farris, Thomas C Krivak, et al.American Journal of Obstetrics and Gynecology|February 4, 2015
Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian cancer in patients 65 years old or olderMichelle R Rowland, Jamie L Lesnock, Coreen Farris, et al.Gynecologic Oncology|April 27, 2023
Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancerTaylor J Orellana, Hayeon Kim, Sushil Beriwal, et al.The American Journal of Surgical Pathology|May 25, 2023
Mutation-specific Mismatch Repair-deficient Benign Endometrial Glands in Endometrial Biopsies and Curettings Are a Biomarker of Lynch Syndrome and Associate With Endometrial Carcinoma DevelopmentShaymaa Hegazy, Randall E Brand, Beth Dudley, et al.Pageof 3